143 related articles for article (PubMed ID: 29212159)
1. LEF1, TFE3, and AR are putative diagnostic markers of solid pseudopapillary neoplasms.
Kim EK; Jang M; Park M; Kim H
Oncotarget; 2017 Nov; 8(55):93404-93413. PubMed ID: 29212159
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology.
McHugh KE; Stelow EB; Harrison GP; Policarpio-Nicolas MLC
Cancer Cytopathol; 2019 Nov; 127(11):700-707. PubMed ID: 31584754
[TBL] [Abstract][Full Text] [Related]
3. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic Utility of LEF1 Immunostain in Cytology Specimens of Solid Pseudopapillary Neoplasm of Pancreas].
Farzaneh T; Nowroozizadeh B; Han M; Lee W
Acta Cytol; 2021; 65(3):250-256. PubMed ID: 33887729
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemistry for SOX-11 and TFE3 as diagnostic markers for solid pseudopapillary neoplasms of the pancreas in FNA biopsies.
Foo WC; Harrison G; Zhang X
Cancer Cytopathol; 2017 Nov; 125(11):831-837. PubMed ID: 29045075
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.
Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
[TBL] [Abstract][Full Text] [Related]
7. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors.
Lu H; Allende D; Liu X; Zhang Y
Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis.
Ohara Y; Oda T; Hashimoto S; Akashi Y; Miyamoto R; Enomoto T; Satomi K; Morishita Y; Ohkohchi N
World J Gastroenterol; 2016 Oct; 22(38):8596-8604. PubMed ID: 27784972
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of SOX11 and TFE3 in Solid-Pseudopapillary Neoplasms of the Pancreas.
Harrison G; Hemmerich A; Guy C; Perkinson K; Fleming D; McCall S; Cardona D; Zhang X
Am J Clin Pathol; 2017 Dec; 149(1):67-75. PubMed ID: 29272888
[TBL] [Abstract][Full Text] [Related]
10. Solid-Pseudopapillary Neoplasm of the Pancreas: A 63-Case Analysis of Clinicopathologic and Immunohistochemical Features and Risk Factors of Malignancy.
Chen H; Huang Y; Yang N; Yan W; Yang R; Zhang S; Yang P; Li N; Feng Z
Cancer Manag Res; 2021; 13():3335-3343. PubMed ID: 33883945
[TBL] [Abstract][Full Text] [Related]
11. High-grade Solid Pseudopapillary Neoplasms of the Pancreas: Distinct Clinicopathological Malignant Features With Intriguing Gene Alterations through a Comparison With the Conventional Type.
Honda S; Yamaguchi H; Aimono E; Hara S; Minamiguchi S; Norose T; Ohike N; Yamochi T; Yasuda M; Moriya T; Shiko Y; Nishihara H; Nagao T
Am J Surg Pathol; 2024 Mar; 48(3):353-363. PubMed ID: 38189381
[TBL] [Abstract][Full Text] [Related]
12. A limited panel of INSM1 and LEF1 immunostains accurately distinguishes between pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm.
Guo W; Farzaneh T; Lee W; Nael A; Li X; Chandan VS
Pathol Res Pract; 2021 Jul; 223():153462. PubMed ID: 34048981
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and immunohistochemical study of 29 cases of solid-pseudopapillary neoplasms of the pancreas in patients under 20 years of age along with detailed review of literature.
Din NU; Rahim S; Abdul-Ghafar J; Ahmed A; Ahmad Z
Diagn Pathol; 2020 Dec; 15(1):139. PubMed ID: 33298094
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic solid pseudopapillary neoplasm of the pancreas: degenerative change rather than high-grade malignant potential.
Kim SA; Kim MS; Kim MS; Kim SC; Choi J; Yu E; Hong SM
Hum Pathol; 2014 Jan; 45(1):166-74. PubMed ID: 24321526
[TBL] [Abstract][Full Text] [Related]
15. 'Microcystic pattern' should be recognised as part of the morphological spectrum of solid-pseudopapillary neoplasm of the pancreas.
Abe A; Ohishi Y; Miyazaki T; Ozono K; Mochidome N; Saeki K; Nakamura M; Oda Y
Histopathology; 2018 Jan; 72(2):216-226. PubMed ID: 28858381
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
[TBL] [Abstract][Full Text] [Related]
17. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas.
Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q
Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392
[TBL] [Abstract][Full Text] [Related]
18. Distinct Protein Expression Profiles of Solid-Pseudopapillary Neoplasms of the Pancreas.
Park M; Lim JS; Lee HJ; Na K; Lee MJ; Kang CM; Paik YK; Kim H
J Proteome Res; 2015 Aug; 14(8):3007-14. PubMed ID: 26148796
[TBL] [Abstract][Full Text] [Related]
19. Solid-pseudopapillary neoplasms of the pancreas in men and women: do they differ?
Takahashi Y; Hiraoka N; Onozato K; Shibata T; Kosuge T; Nimura Y; Kanai Y; Hirohashi S
Virchows Arch; 2006 May; 448(5):561-9. PubMed ID: 16523258
[TBL] [Abstract][Full Text] [Related]
20. Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis.
Meriden Z; Shi C; Edil BH; Ellison T; Wolfgang CL; Cornish TC; Schulick RD; Hruban RH
Am J Surg Pathol; 2011 Jul; 35(7):981-8. PubMed ID: 21677537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]